Analystreport

Novelion Therapeutics Inc. (NASDAQ: NVLN) was given a new $9.00 price target on by analysts at Royal Bank Of Canada. They now have a "hold" rating on the stock.

NOVELION THERAPEUTICS INC COMMON SHARES  (NVLN) 
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novelion.com